GlassScriptPhysician profile
Margot Potter
NPI 1033436084
$3,745.84
in general payments reported to CMS, 2019-2025
35 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $390 · 2021: $496 · 2022: $660 · 2023: $721 · 2024: $588 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,592.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $605.82 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $241.27 | 2022-2025 | |
| Ethicon US, LLC | $212.26 | 2022-2025 | Dermabond Prineo, Ethicon, Enseal |
| Coopersurgical, INC. | $190.55 | 2019-2022 | |
| Hologic Sales and Service, LLC | $189.73 | 2019-2024 | Acessa Provu System, Aptima, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $170.29 | 2023-2025 | Veozah, Myrbetriq |
| Baxter Healthcare | $162.80 | 2020-2021 | |
| Exeltis, USA INC. | $152.92 | 2019-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $141.06 | 2019-2025 | |
| Scynexis, INC. | $137.16 | 2022 | |
| Therapeuticsmd, INC. | $131.39 | 2019-2022 | |
| Myriad Women'S Health, INC. | $126.18 | 2023 | Myrisk |
| Millicent US INC | $117.81 | 2023-2025 | Intrarosa, Femlyv |
| Shield Therapeutics INC | $114.48 | 2023-2024 | Accrufer |
| Mylan Pharmaceuticals INC. | $108.97 | 2019-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $103.42 | 2020-2022 | |
| Sage Therapeutics, LLC | $97.34 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $90.22 | 2021-2022 | |
| Minerva Surgical, INC | $75.78 | 2019-2024 | |
| Amag Pharmaceuticals, INC. | $67.72 | 2019-2020 | |
| Aspira Women'S Health INC | $67.67 | 2021 | |
| Pfizer INC. | $67.07 | 2019-2023 | |
| Avion Pharmaceuticals | $54.02 | 2019-2021 | |
| Duchesnay USA Incorporated | $49.32 | 2019 | |
| Sumitomo Pharma America, INC. | $48.00 | 2023-2024 | Myfembree |
| Daiichi Sankyo INC. | $31.95 | 2020-2021 | |
| Amgen INC. | $28.44 | 2019 | |
| Myovant Sciences INC. | $27.33 | 2022 | |
| Conmed Corporation | $25.14 | 2024 | Airseal, Visiclear |
| Merck Sharp & Dohme LLC | $24.86 | 2019-2021 | |
| Allergan, INC. | $23.88 | 2020 | |
| Monaghan Medical Corporation | $18.35 | 2023 | Aerochamber |
| Urovant Sciences INC | $15.94 | 2022 | |
| Exact Sciences Corporation | $14.75 | 2023 | Cologuard Collection Kit |
| Organon LLC | $11.95 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margot Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.